top of page

Precision in Clinical Trials Summit - San Diego 

Trusted Trial Execution Meets Digital Innovation in Neurodegenerative Drug Development

HSG Clinical Research (HSGCR) and Koneksa Health bring together digital innovation and trusted clinical operations to accelerate drug development and deliver regulatory-ready outcomes.

image.png
image.png

Contact us

image.png
image.png
human-brain-connections-medical-educational-purposes-using-generative-ai.jpg

About HSG Clinical Research

HSG Clinical Research (HSGCR) is a leading full-service clinical research organization (CRO) and trusted partner in neurodegenerative drug development. Through close collaboration with sponsors, HSGCR designs and executes complex neurodegenerative clinical trials in Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and related disorders. With decades of scientific and operational expertise, a global network of credentialed research sites, and strong ties across industry, academia, and patient communities, HSGCR delivers the insight, precision, and execution required to accelerate neuro-focused drug development and bring new treatments to patients faster.

HSGCR Resources

Koneksa Resources

AdobeStock_182272692.jpeg

About Koneksa Health

Koneksa transforms complex multimodal data into actionable clinical insights. Its platform unifies digital biomarkers, wearable sensor data, patient-reported outcomes, and clinical measures to deliver a deeper view of disease, treatment response, and patient well-being. With a remote-first, patient-centric approach, Koneksa reduces site burden, improves accessibility, and captures continuous real-world evidence. By accelerating trial timelines, enhancing decision-making, and supporting participant retention, Koneksa advances therapeutic innovation from early discovery through post-market studies.

Advancing patient-focused, data-rich, efficient trials that move neurodegenerative therapies from discovery to delivery

image.png
bottom of page